Through qPCR analysis, we found that both GAD2 and GAT1 (SLC6A1) mRNA levels were significantly reduced in the PFC of 8 weeks-old offspring from the GDM group compared to the control group. The gene discussed is SLC6A1; the disease is gestational diabetes.